Stem Cell Transplant for Bone Marrow Failure Syndromes
Public ClinicalTrials.gov record NCT00176878. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Bone Marrow Transplantation for Non-Malignant Congenital Bone Marrow Failure Disorders
Study identification
- NCT ID
- NCT00176878
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Masonic Cancer Center, University of Minnesota
- Other
- Enrollment
- 10 participants
Conditions and interventions
Interventions
- Stem cell transplant Procedure
- Fludarabine monophosphate Drug
- Total lymphoid irradiation Procedure
- Busulfan Drug
- anti-thymocyte globulin Biological
Procedure · Drug · Biological
Eligibility (public fields only)
- Age range
- Up to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2000
- Primary completion
- Feb 28, 2009
- Completion
- Feb 28, 2009
- Last update posted
- Dec 27, 2017
2000 – 2009
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Minnesota Medical Center | Minneapolis | Minnesota | 55455 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00176878, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 27, 2017 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00176878 live on ClinicalTrials.gov.